CIK 0001761612
- Non-accelerated filer
- Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-05 | Thompson Travis Alvin Chief Financial Officer | Sale | −79 | $3.57 | $282 | 64,449 |
| 2026-10-02 | Thompson Travis Alvin Chief Financial Officer | Sale | −893 | $3.47 | $3K | 64,528 |
| 2026-07-15 | Thompson Travis Alvin Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2026-07-06 | Thompson Travis Alvin Chief Financial Officer | Sale | −104 | $4.31 | $448 | 64,441 |
| 2026-07-02 | Thompson Travis Alvin Chief Financial Officer | Sale | −819 | $4.27 | $3K | 64,545 |
| 2026-04-06 | Thompson Travis Alvin Chief Financial Officer | Sale | −102 | $5.05 | $515 | 65,364 |
| 2026-04-02 | Thompson Travis Alvin Chief Financial Officer | Sale | −799 | $4.91 | $4K | 65,466 |
| 2026-02-03 | Thompson Travis Alvin Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +58,000 | 58,000 | ||
| 2026-01-05 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −1,115 | $6.45 | $7K | 66,265 |
| 2026-01-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Grant or award | +37,500 | 68,697 | ||
| 2026-01-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −1,317 | $6.80 | $9K | 67,380 |
| 2026-01-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-10-03 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −103 | $8.41 | $866 | 31,197 |
| 2025-10-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −221 | $8.40 | $2K | 31,300 |
| 2025-07-03 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −100 | $7.44 | $744 | 31,521 |
| 2025-07-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −206 | $7.09 | $1K | 31,621 |
| 2025-04-03 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −109 | $7.48 | $815 | 31,827 |
| 2025-04-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −210 | $8.02 | $2K | 31,936 |
| 2025-01-06 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −2,686 | $15.00 | $40K | 32,146 |
| 2025-01-03 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −159 | $14.75 | $2K | 34,832 |
Page 1 of 3 · 43 trades